What is the best chance for long-term survival in aplastic anemia?

Study for the PaEasy Emergency Medicine Test. Prepare with detailed questions and explanations. Get ready to ace your exam!

Multiple Choice

What is the best chance for long-term survival in aplastic anemia?

Explanation:
Allogeneic hematopoietic stem cell transplantation (bone marrow transplant) offers the best chance for long-term survival in aplastic anemia because it permanently replaces the defective marrow with healthy donor cells, reconstituting both blood cell production and the immune system. When a patient is younger and has a matched donor (often a sibling), the cure rates after transplant are high and long-term survival is superior to other approaches. Immunosuppressive therapy can control the disease for some time by dampening the immune attack on the marrow, but it does not reliably provide a durable cure and many patients remain transfusion-dependent or experience relapse. Chemotherapy alone doesn’t address the underlying marrow failure and is not curative. Stem cell transplantation, specifically from a matched donor, achieves durable hematopoiesis and immune reconstitution, making it the best option for long-term survival in appropriate patients.

Allogeneic hematopoietic stem cell transplantation (bone marrow transplant) offers the best chance for long-term survival in aplastic anemia because it permanently replaces the defective marrow with healthy donor cells, reconstituting both blood cell production and the immune system. When a patient is younger and has a matched donor (often a sibling), the cure rates after transplant are high and long-term survival is superior to other approaches. Immunosuppressive therapy can control the disease for some time by dampening the immune attack on the marrow, but it does not reliably provide a durable cure and many patients remain transfusion-dependent or experience relapse. Chemotherapy alone doesn’t address the underlying marrow failure and is not curative. Stem cell transplantation, specifically from a matched donor, achieves durable hematopoiesis and immune reconstitution, making it the best option for long-term survival in appropriate patients.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy